Navakanth Raju Ramayanam, Sarad Pawar Naik Bukke, Murali Krishna Moka, Himanshu Dehingia, Aditya Bordoloi, Riya Debbarma et al. Advances in nanoparticle-based doxorubicin delivery: precision strategies for targeted treatment of triple-negative breast cancer. // Discover Nano. – 2025. – DOI: 10.1186/s11671-025-04308-5. – URL: https://doi.org/10.1186/s11671-025-04308-5
Navakanth Raju Ramayanam, Sarad Pawar Naik Bukke, Murali Krishna Moka, Himanshu Dehingia, Aditya Bordoloi, Riya Debbarma, Purushothama Reddy Kudumula, Balakrishna Vuyyala, P. Dharani Prasad, & Akugizibwe Catherine (2025). Advances in nanoparticle-based doxorubicin delivery: precision strategies for targeted treatment of triple-negative breast cancer. Discover Nano. https://doi.org/10.1186/s11671-025-04308-5
Navakanth Raju Ramayanam, et al. “Advances in nanoparticle-based doxorubicin delivery: precision strategies for targeted treatment of triple-negative breast cancer.” Discover Nano, 2025. doi:10.1186/s11671-025-04308-5.
@article{Ramayanam2025,
title = {Advances in nanoparticle-based doxorubicin delivery: precision strategies for targeted treatment of triple-negative breast cancer},
author = {Ramayanam, Navakanth Raju and Bukke, Sarad Pawar Naik and Moka, Murali Krishna and Dehingia, Himanshu and Bordoloi, Aditya and Debbarma, Riya and Kudumula, Purushothama Reddy and Vuyyala, Balakrishna and Prasad, P. Dharani and Catherine, Akugizibwe},
journal = {Discover Nano},
year = {2025},
doi = {10.1186/s11671-025-04308-5},
url = {https://doi.org/10.1186/s11671-025-04308-5}
}